🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're thrilled to announce the release of our Gen3 Stent Delivery System, designed to enhance precision and ease of use in #TADV. More on #LimFlow Stent Delivery System: bit.ly/41R97YG

We were honored to welcome #LimFlow patient John O'Connell, who went from facing major amputation to regaining mobility. His journey highlights why we’re passionate about providing hope to #CLTI patients with limited options. Watch John's story: bit.ly/3FuHH3o

Congratulations to Dr. Nicholas Petruzzi and the research team on receiving Abstract of the Year at the 2025 SIR Annual Scientific Meeting! Read more here: bit.ly/4cb5ams #SIR2025 #LimbSalvage #CLTI #VascularInnovati

Congratulations to the team at NYU Suffolk, for successfully performing their first LimFlow #TADV procedure! This marks an exciting milestone in advancing treatment options for patients with chronic limb ischemia. Learn more about #LimFlow: bit.ly/3YvXQeo #LimFlow

Congratulations to Drs. Spyridon Monastiriotis and Turna Mukherjee, along with the team at South Shore University Hospital, for successfully performing their first LimFlow #TADV procedure! Learn more about #LimFlow: bit.ly/3YvXQeo #LimFlow #CLTI #amputation

Heading to VAM 2025? Visit us at booth #521 on June 5–6! #LimFlow is reshaping what's possible for #CLTI. Learn how #TADV is driving real-world limb salvage—and why more physicians are choosing a limb-first strategy. More: bit.ly/4k3h3xP #VAM2025 #LimbSalvage

Join Inari Medical for an Exclusive Learn & Dine at #VAM25 in New Orleans! Discover the latest in vascular care as we explore: - Tracing the Clinical Evolution of #TADV - Applying #PROMISE to Real-World #CLTI Care - Opportunity in arterial thrombectomy with #Artix Don’t miss

Join us for an Exclusive Learn & Dine at #VAM25 in New Orleans! Don’t miss this chance to connect with peers, expand your knowledge, and be part of the conversation shaping tomorrow’s care. Register: bit.ly/vam25-dinner #InariMedical #LimFlow #PROMISE #Artix #CLTI #TADV

Going to New Cardiovascular Horizons? Join #LimFlow and #Artix at Booth #102 as we bring forward-thinking solutions to some of the most complex vascular challenges. Come see how we’re working together to move from occlusion to opportunity. More on #LimFlow: bit.ly/4k3h3xP #NCVH2025

Managing complex #CLTI or tough arterial occlusions? Visit LimFlow at Booth #521 to explore #TADV, chat with experts, and learn about real limb salvage strategies. Join our exclusive dinner on #LimFlow & #Artix! Register here: bit.ly/vam25-dinner

If you’re focused on improving outcomes for no-option CLTI patients, these sessions are where innovation meets evidence. These sessions spotlight the data, direction, and disruption reshaping vascular care. Be in the room where the future of CLTI treatment is being defined.

BREAKTHROUGH DATA AT #VAM25! In a highly anticipated plenary presentation, long-term data comparing #TADV versus Standard of Care in no-option #CLTI patients was unveiled. Congratulations to the investigators, Dr. Dua and all who are driving innovation forward. #LimFlow #CLTI

At #VAM2025, Dr. Anahita Dua shared long-term data showing #TADV outperforms standard care in no-option #CLTI patients—offering new hope for those once considered untreatable. A pivotal moment in limb salvage care. #LimbSalvage #VascularSurgery #TADV #VAM25

#ICYMI: BREAKTHROUGH DATA AT #VAM25! In a highly anticipated plenary presentation, long-term data comparing #TADV versus Standard of Care in no-option #CLTI patients was unveiled. Congratulations to the investigators, Dr. Dua and all who are driving innovation forward.

Heading to CORS/VASC at the Shore? Stop by the LimFlow table to discover how we’re revolutionizing care for high-risk #CLTI patients. Explore real-world outcomes, dive into case insights, and get your questions answered by our expert team. Let’s connect and talk limb salvage.

#ICYMI: Dr. Anahita Dua presented powerful long-term data comparing Transcatheter Arterialization of the Deep Veins (TADV) to standard therapy in no-option CLTI patients. The key takeaway? TADV outperforms standard of care (SoC) in high-risk CLTI patients. #LimbSalvage #CLTI

Thank you to everyone who joined us at CORS/VASC! We’re grateful for the great conversations and the chance to connect with passionate clinicians. Your commitment to CLTI care drives us forward. Let’s keep the momentum going! #CORS2025 #LimbSalvage #CLTI #TADV #LimFlow

This breakthrough marks a new era of hope for patients once facing amputation — offering them a durable alternative through transcatheter arterialization of deep veins (TADV). Read more: bit.ly/4lkzjDe #LimbSalvage #CLTI #TADV #LimFlow #Endovascular #VascularSurgery

Hot off the press! Dr. Anahita Dua and coauthors share important new findings. In this U.S. registry, nearly half underwent major amputation and one-third died within a year—underscoring the urgent need for novel limb salvage therapies. Read more: bit.ly/44lNYbQ

LimFlow is heading to APMA to show how our tech supports #TADV in CLTI care. Don’t miss our abstracts on July 26! #CLTI #LimFlow #medicalinnovation